Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Ocrelizumab for Psychosis by Autoimmunity (OPA)

Author:Joseph Masdeu  

Topic:Autoimmune Neurology  

Program Number:P1.081  

Author Institution:Houston Methodist Neurological Institute, Houston, TX